Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.53 - $0.93 $29,354 - $51,508
55,385 Added 18.94%
347,764 $201,000
Q4 2023

Feb 14, 2024

BUY
$0.63 - $1.14 $93,042 - $168,362
147,686 Added 102.07%
292,379 $242,000
Q3 2023

Nov 14, 2023

BUY
$1.12 - $1.88 $9,513 - $15,968
8,494 Added 6.24%
144,693 $163,000
Q2 2023

Aug 14, 2023

BUY
$1.31 - $2.04 $23,103 - $35,977
17,636 Added 14.87%
136,199 $217,000
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $19,860 - $31,954
9,832 Added 9.04%
118,563 $284,000
Q3 2022

Mar 03, 2023

SELL
$1.96 - $3.14 $19,270 - $30,872
-9,832 Reduced 8.29%
108,731 $222,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $15,090 - $24,174
7,699 Added 7.62%
108,731 $223,000
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $18,067 - $36,690
13,898 Added 15.95%
101,032 $196,000
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $9,548 - $14,098
4,063 Added 4.89%
87,134 $214,000
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $6,467 - $12,714
2,215 Added 2.74%
83,071 $267,000
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $6,533 - $8,698
1,312 Added 1.65%
80,856 $424,000
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $10,803 - $23,167
4,220 Added 5.6%
79,544 $436,000
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $27,932 - $54,516
10,384 Added 15.99%
75,324 $205,000
Q4 2020

Feb 16, 2021

BUY
$3.17 - $4.49 $45,945 - $65,078
14,494 Added 28.73%
64,940 $207,000
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $4,896 - $8,543
1,643 Added 3.37%
50,446 $202,000
Q2 2020

Aug 14, 2020

SELL
$2.29 - $4.24 $10,030 - $18,571
-4,380 Reduced 8.24%
48,803 $192,000
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $22,882 - $41,778
9,495 Added 21.73%
53,183 $216,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $17,186 - $20,650
6,793 Added 18.41%
43,688 $131,000
Q1 2019

May 15, 2019

BUY
$2.51 - $3.73 $7,002 - $10,406
2,790 Added 8.18%
36,895 $110,000
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $4,548 - $7,610
2,861 Added 9.16%
34,105 $81,000
Q2 2018

Aug 14, 2018

SELL
$2.26 - $4.65 $11,166 - $22,975
-4,941 Reduced 13.65%
31,244 $71,000
Q4 2017

Feb 14, 2018

SELL
$3.26 - $4.78 $15,224 - $22,322
-4,670 Reduced 11.43%
36,185 $118,000
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $142,175 - $181,396
40,855
40,855 $180,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.